Posted in | News | Medical Robotics

Hansen Medical to Showcase Magellan Robotic System at VIVA 2012 Conference

Hansen Medical, a global leader in intravascular robotics and the developer of robotic technology for accurate 3D control of catheter movement, today announced it will exhibit its Magellan™ Robotic System at the Vascular InterVentional Advances (VIVA) conference, from October 9-12 at the Wynn Hotel in Las Vegas. The Company will be conducting product demonstrations and exhibiting the Magellan Robotic System at Booth 102.

In addition, John Laird, M.D., Medical Director of the Vascular Center at UC Davis Medical Center in Sacramento, CA, will be featuring the Magellan Robotic System in his presentation at VIVA, titled "New Strategies, Devices, and Techniques for Carotid Artery Stenting" on Thursday, October 11.

"With the initial U.S. launch of the Magellan Robotic System underway, we are excited for the opportunity to further showcase our technology at this important annual meeting of leading clinicians focused on the peripheral vasculature," said Bruce Barclay, president and CEO of Hansen Medical. "We are seeing strong clinical interest in Magellan and are pleased with our robust and growing pipeline of potential transactions. The Magellan Robotic System has the potential to enhance vascular surgery and allow hospitals and health systems to improve the efficiency and utilization of their most profitable assets -- their operating rooms and cath labs -- by reducing procedure times and streamlining endovascular procedures."

About the Magellan™ Robotic System

Hansen Medical's Magellan Robotic System is based upon the flexible robotic technology incorporated in the Sensei® X Robotic Catheter System currently sold in the U.S. and Europe, which has been used in more than 8,000 patients, but includes a number of key enhancements. In particular, the Magellan Robotic System:

  • Provides solid catheter stability for placement of therapeutic devices.
  • Is designed to enable predictable procedure times and increased case throughput.
  • Allows for independent, individual robotic control of the distal tips of both the outer sheath and the inner leader catheter, as well as robotic manipulation of standard guidewires.
  • Is designed to allow for sufficient extension inside the body to access hard to reach peripheral anatomy.
  • Preserves the open architecture featured in the Sensei System to allow for the subsequent use of many 6F therapeutic devices on the market today.
  • Is designed to potentially reduce physician radiation exposure and fatigue by employing a remote physician workstation.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Auris Surgical Robotics Inc.. (2019, February 20). Hansen Medical to Showcase Magellan Robotic System at VIVA 2012 Conference. AZoRobotics. Retrieved on November 21, 2024 from https://www.azorobotics.com/News.aspx?newsID=3280.

  • MLA

    Auris Surgical Robotics Inc.. "Hansen Medical to Showcase Magellan Robotic System at VIVA 2012 Conference". AZoRobotics. 21 November 2024. <https://www.azorobotics.com/News.aspx?newsID=3280>.

  • Chicago

    Auris Surgical Robotics Inc.. "Hansen Medical to Showcase Magellan Robotic System at VIVA 2012 Conference". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=3280. (accessed November 21, 2024).

  • Harvard

    Auris Surgical Robotics Inc.. 2019. Hansen Medical to Showcase Magellan Robotic System at VIVA 2012 Conference. AZoRobotics, viewed 21 November 2024, https://www.azorobotics.com/News.aspx?newsID=3280.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.